Clinical trial
A Randomized Placebo-controlled Phase II Study of Clarithromycin or Placebo Combined With VCD Induction Therapy Prior to High-dose Melphalan With Stem Cell Support in Patients With Newly Diagnosed Multiple Myeloma
NCT02573935 is registered in ClinicalTrials.gov with Henrik Gregersen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Placebo-controlled Phase II Study of Clarithromycin or Placebo Combined With VCD Induction Therapy Prior to High-dose Melphalan With Stem Cell Support in Patients With Newly Diagnosed Multiple Myeloma
- Lead sponsor
- Henrik Gregersen
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- January 31, 2015
- Completion date
- September 30, 2016
- Enrollment
- 58 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.